WDM(SH:600055) Cai Jing Wang·2025-09-02 13:56Core Viewpoint - The company is addressing concerns regarding the slow launch of new high-end products, emphasizing its focus on research and development capabilities and recent technological advancements [1] Group 1: R&D and Product Development - The company's R&D team constitutes one-third of its workforce, focusing on high-end CT technology and self-developed core components [1] - The company has achieved mass production of the world's first helium-free MR, eliminating the risk associated with helium supply shortages [1] - The quantum DSA technology, utilizing self-controlled rare earth detectors, is set to revolutionize vascular imaging by introducing low-dose procedures [1] Group 2: Communication and Transparency - The management has committed to timely announcements regarding new product registration certifications as they are obtained [1]